Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data & AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma & Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Authors / Coral Barbas

Coral Barbas

Coral Barbas’ research career started at Biochemistry Lab with Prof Emilio Herrera, developing and validating chromatographic methods for bioanalysis. In 2005-06 she obtained a Marie Curie fellowship for Experienced Researchers at Kings College London, where she was introduced to Metabolomics concepts and workflow. Once back to San Pablo CEU University she succeeded in getting funding from public and private sources as well as from the university to establish the Centre for Metabolomics and Bioanalysis (CEMBIO), that she has headed since then. Currently CEMBIO is a leading lab in Metabolomics using mass spectrometry coupled to different separation techniques (GC-MS, LC-MS and CE-MS). It offers: searching metabolic changes without a priori hypothesis to unveil mechanism of drug action, toxicity or resistance, patient stratification based on non-target metabolomics, as well as target pathway analysis. CEMBIO has the capacity for tackling aspects such as experimental design, analytical methods, appropriate statistical methods for metabolomics data treatment and biochemical interpretation. Techniques for target analysis are also available and method development is part of the expertise. With these purposes CEMBIO´s group includes over 20 researchers in all levels from technicians to pre-doc, postdocs and staff with expertise in analytical techniques, statistics, pharmacy and biochemistry. Currently she is Visiting Professor at Imperial College London (UK) collaborating with Prof Jeremy Nicholson´s group and at Bialystok Medical University (Poland) collaborating with the doctorate program in “OMICS” technologies. She has published over 160 research papers all in journals with high impact factors.

  • Contributions
Fields & Applications Omics

Fishing for Insight

January 25, 2017

The power of metabolomics lies in casting a wide net.

1 min read

Fishing for Insight

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.